Coinbase’s Roadmap Update Sparks Price Gains for 2 Altcoins

Coinbase, one of the leading cryptocurrency exchanges, has announced the addition of Bio Protocol (BIO) and Euler (EUL) to its asset listing roadmap.

The announcement, posted on X, has triggered significant market reactions, with both assets experiencing notable price increases.

Bio Protocol and Euler Join Coinbase’s Listing Roadmap

The exchange notified users that the launch of trading for BIO and EUL remains contingent on market-making support and sufficient technical infrastructure. Coinbase will provide a separate announcement once these conditions are met, which is a standard procedure to manage expectations and mitigate risks for users.

It also cautioned that depositing these assets before an official listing could result in permanent loss of funds. Meanwhile, BIO, an Ethereum-based ERC-20 token with the contract address 0xcb1592591996765ec0efc1f92599a19767ee5ffa, saw an immediate surge following the news.

The token’s price rose from $0.0612 to $0.0669, marking a 9.31% increase. The uptrend continued. Furthermore, at the time of this report, BIO was trading at $0.0733, reflecting an 18.99% gain since the announcement.

EUL, another ERC-20 token with the contract address 0xd9fcd98c322942075a5c3860693e9f4f03aae07b, experienced an even sharper initial spike.

The token jumped from $13.51 to $16.50 , quickly post-announcement. This represented a 22.22% uptick. However, EUL quickly shed most of its gains, stabilizing at $13.52 by press time, a modest 0.17% rise.

This development follows a consistent pattern of Coinbase roadmap updates driving significant price movements. On July 25, the exchange added ResearchCoin (RSC) to its roadmap, triggering an approximately 82% price surge.

Earlier last week, Coinbase included BankrCoin (BNKR), Jito Staked SOL (JITOSOL), and Metaplex (MPLX) in its roadmap, with similar market reactions reported. Notably, the exchange listed JITOSOL and MPLX shortly after. However, BNKR trading is yet to be announced.

The current roadmap now features QCAD (QCAD), BIO, EUL, BNKR, and RSC.

“This is not an exhaustive list of all assets which we have decided to list. Any asset not referenced in the above lists does not preclude any such asset from potential listing,” Coinbase noted.

The exchange also emphasized that assets may be delayed or removed from consideration for listing due to various factors. Thus, the roadmap should not be relied upon as a guarantee or promise of listing.

Bithumb Announces Chainbase (C) Listing

Notably, Coinbase isn’t the only exchange influencing prices. South Korean exchanges have also been significant drivers of price movements. For instance, in an official announcement today, Bithumb revealed that it will be listing Chainbase (C).

In the aftermath of this news, the price quickly rose by approximately 26.03%, increasing from $0.365 to $0.465. As of the latest update, the altcoin was trading at $0.404, reflecting an 11.3% gain.

Chainbase (C) Price Performance. Source: TradingView

The exchange confirmed that trading for C will begin on July 29 at 5:00 PM (KST), with the altcoin available for trading against the Korean Won (KRW). The base price is set at 526 KRW.